These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 27491214

  • 1. The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy.
    Regier DS, Proia RL, D'Azzo A, Tifft CJ.
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):663-73. PubMed ID: 27491214
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
    Satoh H, Yamato O, Asano T, Yamasaki M, Maede Y.
    J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
    [Abstract] [Full Text] [Related]

  • 9. GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies.
    Leal AF, Benincore-Flórez E, Solano-Galarza D, Garzón Jaramillo RG, Echeverri-Peña OY, Suarez DA, Alméciga-Díaz CJ, Espejo-Mojica AJ.
    Int J Mol Sci; 2020 Aug 27; 21(17):. PubMed ID: 32867370
    [Abstract] [Full Text] [Related]

  • 10. Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients.
    Welford RWD, Farine H, Steiner M, Garzotti M, Dobrenis K, Sievers C, Strasser DS, Amraoui Y, Groenen PMA, Giugliani R, Mengel E.
    Mol Genet Metab Rep; 2022 Mar 27; 30():100843. PubMed ID: 35242574
    [Abstract] [Full Text] [Related]

  • 11. [Recent advances in the diagnosis and treatment of lysosomal storage diseases].
    Wu XR, Bao XH.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug 18; 37(4):440-4. PubMed ID: 16086072
    [Abstract] [Full Text] [Related]

  • 12. Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan.
    Weismann CM, Ferreira J, Keeler AM, Su Q, Qui L, Shaffer SA, Xu Z, Gao G, Sena-Esteves M.
    Hum Mol Genet; 2015 Aug 01; 24(15):4353-64. PubMed ID: 25964428
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.
    Kohyama M, Yabuki A, Ochiai K, Nakamoto Y, Uchida K, Hasegawa D, Takahashi K, Kawaguchi H, Tsuboi M, Yamato O.
    BMC Vet Res; 2016 Mar 31; 12():67. PubMed ID: 27036194
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical features of GM1 and GM2 gangliosidosis in own observation].
    Steczkowska M, Gergont A, Kroczka S, Nowak A.
    Przegl Lek; 2008 Mar 31; 65(11):819-23. PubMed ID: 19205369
    [Abstract] [Full Text] [Related]

  • 18. Glycosphingolipid disorders of the brain.
    Boomkamp SD, Butters TD.
    Subcell Biochem; 2008 Mar 31; 49():441-67. PubMed ID: 18751922
    [Abstract] [Full Text] [Related]

  • 19. Chitotriosidase as a biomarker for gangliosidoses.
    Kim S, Whitley CB, Jarnes JR.
    Mol Genet Metab Rep; 2021 Dec 31; 29():100803. PubMed ID: 34646735
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.